Law firm Bell, Boyd & Lloyd LLP, which has offices in Chicago and Washington, D.C., opened an office in San Diego on Feb. 13 that will serve as the center for its life sciences group.

The local office’s 13 attorneys and credentialed specialists offer corporate, patent procurement and patent portfolio management services to biopharmaceutical and other venture-funded and emerging companies.

Leading the team are Stephanie Seidman, a prominent biotechnology patent attorney who joins Bell Boyd as a partner from Fish & Richardson P.C., and partner David Fisher, who formerly managed San Diego’s Fisher Thurber LLP. He will lead the corporate and emerging company practice in the office.

Mike Abernathy, managing partner in the Chicago office, said the firm noticed a steady growth in corporate and venture capital clients during the last two and a half years as it developed its life sciences practice. Last year, he said the firm made in excess of $6 million in that area.

“We were looking to further that growth and started looking at other areas that had life sciences and were venture-funded, and we very quickly got to San Diego,” he said.

Seidman said the firm has “an excellent client base” mostly composed of emerging and startup companies that have received some venture funding and some that have been funded by Big Pharma.

Initial clients include Catalyst Biosciences Inc., the Scripps Clinic and Research Foundation and Ligand Pharmaceuticals Inc.

Bell Boyd’s San Diego office is located at the Gateway at Torrey Hills, 3580 Carmel Mountain Road.

“We should see some movement of pent-up demand by this summer, but higher loan limits need to be implemented fully and promptly to have maximum benefit,” said Richard Gaylord, president of the realtors group and a broker with Re/Max in Long Beach, Calif.